Elevated Areg levels are linked to pathogenic airway remodeling and fibrotic lung allograft dysfunction (16), and Areg is increased in epithelial cells of patients with asthma and during chronic obstructive pulmonary disease, where it promotes epithelial cell proliferation and mucin production (63–65). This evidence concerns the gene AREG and chronic obstructive pulmonary disease.